Description
Parkinson’s disease (PD) is the second most common neurodegenerative disorder and arguably the fastest growing neurological disorder worldwide. The prevalence of PD increases with age, especially in adults over 65, and the population of people living with PD is projected to double over the next two decades. This suggests that the overall global burden of disease will escalate as will the need for optimization of management of both the motor and non-motor features of this illness. While primarily characterized as a movement disorder that has multifactorial etiology, PD is increasingly recognized to have associated neuropsychiatric symptoms that are challenging to manage and may become equally debilitating as the motor symptoms. Clinical manifestations of PD include motor symptoms (tremor, bradykinesia, rigidity, gait and balance impairment), and non-motor symptoms (autonomic dysfunction, mood disorders, cognitive impairment). Pathologically, PD involves the degeneration of dopaminergic neurons in the substantia nigra pars compacta and associated deposition of misfolded alpha synuclein aggregates called Lewy bodies, which are pathological markers of PD. Hence, dopamine replacement therapy is traditionally used in the management of PD motor symptoms. However, there is limited understanding behind neuropathological mechanisms giving rise to neuropsychiatric symptoms in PD to develop target treatments. Furthermore, undesirable psychiatric effects of dopaminergic agents as well as mood disturbances related to a co-occurring dementia create another layer of complexity in caring for people with PD. A collaborative care approach between psychiatrists and neurologists would optimize the management of this complex neuropsychiatric condition. The session will review the epidemiology and diagnostic criteria of PD, with an emphasis on the neuropsychiatric features, including Lewy Body Dementia. We will review the role of psychiatrists and neurologists in the management of PD emphasizing the importance of collaboration for optimized quality and safety of patient care. We will discuss a few complicated cases related to PD neuropsychiatric symptoms, their management, and areas for opportunity to further advance patient care utilizing a collaborative care approach, reflecting upon the further need for research in this area.
Format
Recorded webinar.
This content was recorded during the APA 2023 Annual Meeting.
Learning Objectives
- Critically review the current knowledge of Parkinson’s disease epidemiology, pathophysiology, diagnosis, and management
- Evaluate neuropsychiatric symptoms in Parkinson’s disease and differentiate symptoms related to Parkinson’s disease dementia (PDD) and Dementia with lewy bodies (DLB)
- Analyze clinical cases and examine how a collaborative care approach involving psychiatrists and neurologists can improve quality and safety of patient care in Parkinson’s disease
Target Audience
Medical Students, Residents/Fellows, Psychiatrists, non-psychiatrist Physicians
Estimate Time to Complete
Estimated Duration: 1.0 hour
Program Start Date: May 1, 2025
Program End Date: May 1, 2028
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ may do so after completing all sections of the course including the evaluation. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the completion date and hours earned.
Continuing Education Credit
In support of improving patient care, the American Psychiatric Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The APA designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planner Disclosures
The American Psychiatric Association adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Medical Education. Any individuals in a position to control the content of a CME activity — including faculty, planners, reviewers or others — are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
Instructors
- Ebony Dix, MD
- Syeda Arshiya Farheen, MD
Planners
- Vishal Madaan, MD, Chief of Education and Deputy Medical Director at the American Psychiatric Association.
Accessibility for Participants with Disabilities
The American Psychiatric Association is committed to ensuring accessibility of its website to people with disabilities. Please contact the American Psychiatric Association at 202-559-3900, if you require assistance seven (7) business days prior to the start of a live webinar.
Technical Requirements
This internet-based CME activity is best experienced using any of the following:
- The latest and 2nd latest public versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer 11+
This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Acrobat Reader, Microsoft PowerPoint, and Windows Media Player.
Optimal System Configuration:
- Browser: Google Chrome (latest and 2nd latest version), Safari (latest and 2nd latest version), Internet Explorer 11.0+, Firefox (latest and 2nd latest version), or Microsoft Edge (latest and 2nd latest version)
- Operating System: Windows versions 8.1+, Mac OS X 10.5 (Leopard) +, Android (latest and 2nd latest version), or iOS/iPad OS (latest and 2nd latest version)
- Internet Connection: 1 Mbps or higher
Minimum Requirements:
- Windows PC: Windows 8.1 or higher; 1 GB (for 32-bit)/2 GB (for 64-bit) or higher RAM; Microsoft DirectX 9 graphics device with WDDM driver; audio playback with speakers for programs with video content
- Macintosh: Mac OS X 10.5 or higher with latest updates installed; Intel, PowerPC G5, or PowerPC G4 (867MHz or faster) processor; 512 MB or higher RAM; audio playback with speakers for programs with video content
For assistance: Contact educme@psych.org for questions about this activity | Contact learningcenter@psych.org for technical assistance